首页 | 官方网站   微博 | 高级检索  
     

阿立哌唑与利培酮治疗精神分裂症的对照研究
引用本文:胡亚湘,崔炳喜,于浚玫,崔鹏,秦颖.阿立哌唑与利培酮治疗精神分裂症的对照研究[J].天津药学,2010,22(1):41-43.
作者姓名:胡亚湘  崔炳喜  于浚玫  崔鹏  秦颖
作者单位:天津市安定医院,天津,300222
摘    要:目的:比较阿立哌唑与利培酮治疗精神分裂症的疗效和安全性。方法:对符合《中国精神障碍分类与诊断标准》第3版(CCMD-3)精神分裂症诊断标准的50例患者,随机分为两组,分别给予阿立哌唑和利培酮治疗共8周。采用阳性与阴性症状量表(PANSS)和不良反应量表(TESS)评分。结果:治疗8周后阿立哌唑组和利培酮组的显效率分别为72%和76%,差异无显著性(P〉0.05)。两组治疗后各时点PANSS总分及各因子分也无显著性差异(P〉0.05)。阿立哌唑组的主要不良反应为恶心,厌食,呕吐等消化道症状,而锥体外系反应明显低于利培酮组。结论:阿立哌唑和利培酮对精神分裂症疗效相当,不良反应轻,均为疗效好的抗精神病药,阿立哌唑更适合于锥体外系副作用不能耐受的患者。

关 键 词:阿立哌唑  利培酮  精神分裂症  不良反应量表

Comparison of aripiprazole and risperidone in patients with schizophrenia
Hu Yaxiang,Cui Bingxi,Yu Junmei,Cui Peng,Qin Ying.Comparison of aripiprazole and risperidone in patients with schizophrenia[J].Tianjin Pharmacy,2010,22(1):41-43.
Authors:Hu Yaxiang  Cui Bingxi  Yu Junmei  Cui Peng  Qin Ying
Affiliation:Hu Yaxiang,Cui Bingxi,Yu Junmei,Cui Peng,Qin Ying(Tianjin ,ing Hospital,Tianjin 300222)
Abstract:Objective:To compare the efficacy and safety of aripiprazole and risperidone in patients with schizophrenia.Methods:50 adult patients with the disease conforming to the CCMD-3 Diagnostic Criteria for Schizophrenia were randomly allocated to the aripiprazole group(n=25) or the risperidone group(n=25).The subjects were given aripiprazole and risperidone respectively for eight weeks.Positive and Negative Syndrome Scale(PANSS)and Treatment Emergent Side effect Scale(TESS)were used for the evaluation of the effi...
Keywords:aripiprazole  risperidone  schizophrenia  adverse drug effects  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号